Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for December 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Tips Offered for Patient-Provider Opioid Tapering Talks
THURSDAY, Dec. 28, 2017 (HealthDay News) — Helping patients understand individualized reasons for opioid tapering and encouraging them to provide input into the process are key for patient-provider communications, according to a study published in the November issue of the Journal of Pain.
Criteria Developed for Idiopathic Inflammatory Myopathies
THURSDAY, Dec. 28, 2017 (HealthDay News) — New classification criteria have been developed for idiopathic inflammatory myopathies (IIM), according to an article published in the December issue of Arthritis & Rheumatology.
Rituximab Effective for Lupus-Associated Cytopenia
WEDNESDAY, Dec. 27, 2017 (HealthDay News) — Rituximab treatment seems effective for systemic lupus erythematosus (SLE)-associated immune cytopenias, with an overall initial response rate of 86 percent, according to a study published online Dec. 16 in the American Journal of Hematology.
Rheumatic Diseases Associated With Increased Dementia Risk
WEDNESDAY, Dec. 20, 2017 (HealthDay News) — Patients with various rheumatic diseases have an increased risk of dementia, according to a study published online Dec. 15 in the International Journal of Rheumatic Diseases.
RA Exposure In Utero Tied to Increased Disease Risk
TUESDAY, Dec. 19, 2017 (HealthDay News) — Children born to mothers with rheumatoid arthritis may have an increased risk of rheumatoid arthritis, thyroid disease, and epilepsy, according to a study published online Dec. 11 in Arthritis Care & Research.
Male U.S. Doctors Receive Higher Values of Industry Payments
MONDAY, Dec. 18, 2017 (HealthDay News) — Male physicians in the United States received higher values of general payments from industry than females in 2015, according to a research letter published online Dec. 18 in JAMA Internal Medicine.
Year One Results Out for Value-Based Payment Modifier Program
MONDAY, Dec. 18, 2017 (HealthDay News) — Almost 30 percent of eligible practices failed to register and report data in the first year of the Physician Value-Based Payment Modifier program, according to a report published in the December issue of Health Affairs.
Doctors Must Report on at Least 1 Patient, 1 Measure for MACRA
FRIDAY, Dec. 15, 2017 (HealthDay News) — In order to meet the 2017 Medicare and CHIP Reauthorization Act (MACRA) participation reporting deadline and avoid a Medicare payment penalty in 2019, physicians must report on at least one patient and one measure by Dec. 31, and submit to Medicare no later than Feb. 28, 2018, according to a report from the American Medical Association (AMA).
Making Insurers Participate in Marketplace Could Cut Volatility
THURSDAY, Dec. 14, 2017 (HealthDay News) — Requiring insurers that participate in Medicare or Medicaid to also participate in Marketplaces in the same geographic area could improve access to insurance, according to a study published in the December issue of Health Affairs.
Allopurinol Rx More Likely With Eligibility at Diagnosis
TUESDAY, Dec. 12, 2017 (HealthDay News) — Allopurinol prescribing is more likely if patients meet eligibility criteria at diagnosis, according to a research brief published in the November/December issue of the Annals of Family Medicine.
Deceleration in Health Care Spending Growth in 2016
MONDAY, Dec. 11, 2017 (HealthDay News) — Health care spending growth slowed in 2016 following faster growth in 2014 and 2015, according to research published online Dec. 6 in Health Affairs.
CVS-Aetna Merger Has Implications for Doctors’ Offices
TUESDAY, Dec. 5, 2017 (HealthDay News) — CVS Health’s planned purchase of insurance giant Aetna, a $69 billion deal, was announced Sunday.
Poor Agreement for Practitioners in Defining Myofascial Pain
FRIDAY, Dec. 1, 2017 (HealthDay News) — Health care practitioner groups differ regarding the signs and symptoms that define myofascial pain syndrome (MPS), according to a study published online Nov. 1 in PAIN Practice.
Copyright © 2018 ScoutNews, LLC. All rights reserved.